NCT03849729View on ClinicalTrials.gov

Effectiveness and Tolerability of Phentermine in Patients Under Bariatric Surgery

PHASE4CompletedINTERVENTIONAL
Enrollment

92

Participants

Timeline

Start Date

March 1, 2018

Primary Completion Date

April 1, 2020

Study Completion Date

April 1, 2020

Conditions
ObesityMorbid ObesityBariatric SurgeryNon-alcoholic Fatty LiverWeight Loss
Interventions
DRUG

Phentermine

This is a randomized, control trial to investigate the effect and safety of Phentermine in patients with obesity who need a bariatric surgery (BMI \>35 kg/m2 with comorbidities or BMI \> 40 kg/m2).

OTHER

Placebo

his is a randomized, control trial to investigate the effect and safety of Phentermine in patients with obesity who need a bariatric surgery (BMI \>35 kg/m2 with comorbidities or BMI \> 40 kg/m2).

Trial Locations (1)

07760

Hospital Juárez de México, Mexico City

All Listed Sponsors
lead

Hospital Juarez de Mexico

OTHER_GOV

NCT03849729 - Effectiveness and Tolerability of Phentermine in Patients Under Bariatric Surgery | Biotech Hunter | Biotech Hunter